Literature DB >> 874061

Plasma renin and angiotensin II measurement in hypertensive and normal subjects: correlation of basal and stimulated states.

J D Swales, H Thurston.   

Abstract

Plasma renin activity (PRA) and angiotensin II (AII) were measured in peripheral venous samples obtained from the following subgroups: normal ambulant subjects (n = 61): normal subjects after 7 days treatment with a thiazide diuretic (n = 27): hypertensive subjects before and after a thiazide diruretic (n = 35); severely hypertensive subjects after diazoxide treatment (n = 14) and untreated severely hypertensive subjects (n = 27). In addition aortic (n = 27) and renal vein (n =48) samples were taken from the latter group during investigation of possible renovascular hypertension. Values for PRA and AII were clearly correlated in all groups. Further, calculated regression lines of PRA upon AII did not differ significantly from that calculated for normal subjects, with the exception of the intercept of the diazoxide treated group. However, when the regression line for renal venous samples was compared with that calculated for peripheral venous samples of all other subjects (199), there was a relative increase in the ratio of PRA to AII at all values. Thus, except in the renal vein, measurement of AII and PRA appear to reflect changes in activity of the renin-angiotensin system equally well and there is no support for the view that there is a discrepancy between measured AII and PRA in peripheral venous blood in the clinical situations examined here.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 874061     DOI: 10.1210/jcem-45-1-159

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

1.  A comparison of the haemodynamic and hormonal effects of low and conventional dose cyclopenthiazide in normal volunteers.

Authors:  G E McVeigh; M McMaster; T Linton; E Whitehead; G D Johnston
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Renal effects of nadolol in cirrhosis.

Authors:  A Gatta; D Sacerdoti; C Merkel; L Caregaro; M Borsato; M Bolognesi; A Ruol
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

3.  Hypertension, hyperkalaemia and abnormalities of the renin-angiotensin system in diabetes mellitus.

Authors:  J B Ferriss; P A Sullivan; H Gonggrijp; A A Long; D J O'Sullivan
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

4.  Recent pathogenic aspects in essential hypertension and hypertension associated with diabetes mellitus.

Authors:  P Weidmann
Journal:  Klin Wochenschr       Date:  1980-10-01

5.  Indapamide and bendrofluazide: a comparison in the management of essential hypertension.

Authors:  R F Bing; G I Russell; J D Swales; H Thurston
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

6.  Plasma angiotensin II concentrations in diabetic ketoacidosis and in hyperosmolar non-ketotic hyperglycemia.

Authors:  P A Sullivan; H Gonggrijp; M J Crowley; J B Ferriss; D J O'Sullivan
Journal:  Acta Diabetol Lat       Date:  1981 Apr-Jun

7.  Angiotensin II, independent of plasma renin activity, contributes to the hypertension of autonomic failure.

Authors:  Amy C Arnold; Luis E Okamoto; Alfredo Gamboa; Cyndya Shibao; Satish R Raj; David Robertson; Italo Biaggioni
Journal:  Hypertension       Date:  2012-12-24       Impact factor: 10.190

8.  Renin-hyporesponsiveness in essential hypertension. Dissociation between plasma renin and catecholamines or aldosterone following furosemide.

Authors:  C Beretta-Piccoli; P Weidmann; G Keusch; M Grimm; A Meier; Z Glück; W H Ziegler
Journal:  Klin Wochenschr       Date:  1980-05-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.